Wuppertal, Germany

Timo Fleβner


Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2008-2019

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Timo Fleβner: Innovator in Medicinal Chemistry

Introduction

Timo Fleβner is a prominent inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 12 patents. His work primarily focuses on developing novel compounds that have therapeutic applications.

Latest Patents

Fleβner's latest patents include innovative compounds such as azabicyclic carbamates, which serve as alpha-7 nicotinic acetylcholine receptor agonists. This invention relates to novel benzothiophene-, benzofuran-, and indole ureas, which are utilized in producing medicaments aimed at treating and preventing diseases while enhancing perception, concentration, learning, and memory. Another notable patent involves N-biarylamides, which are produced for the treatment and prophylaxis of diseases, as well as for improving cognition, concentration, learning power, and memory.

Career Highlights

Throughout his career, Timo Fleβner has worked with notable companies such as Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in medicinal chemistry.

Collaborations

Fleβner has collaborated with esteemed colleagues, including Frank-Gerhard Böβ and Joachim Luithle. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Timo Fleβner's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in the treatment of various diseases and cognitive enhancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…